Suppr超能文献

川崎病静脉注射免疫球蛋白治疗无反应的预测因素

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease.

作者信息

Park Hyo Min, Lee Dong Won, Hyun Myung Chul, Lee Sang Bum

机构信息

Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea.

出版信息

Korean J Pediatr. 2013 Feb;56(2):75-9. doi: 10.3345/kjp.2013.56.2.75. Epub 2013 Feb 25.

Abstract

PURPOSE

It has been reported that 10% to 20% of children with Kawasaki disease (KD) will not respond to intravenous immunoglobulin (IVIG) treatment. In this study, we aimed to identify useful predictors of therapeutic failure in children with KD.

METHODS

We examined 309 children diagnosed with KD at the Kyungpook National University Hospital and the Inje University Busan Paik Hospital between January 2005 and June 2011. We retrospectively reviewed their medical records and analyzed multiple parameters in responders and nonresponders to IVIG.

RESULTS

Among the 309 children, 30 (9.7%) did not respond to IVIG. They had significantly higher proportion of neutrophils, and higher levels of aspartate aminotransferase, alanine aminotransferase (ALT), total bilirubin, and N-terminal fragment of B-type natriuretic peptide than did responders. IVIG-nonresponders had a significantly longer duration of hospitalization, and more frequently experienced coronary artery lesion, and sterile pyuria. No differences in the duration of fever at initial treatment or, clinical features were noted.

CONCLUSION

Two independent predictors (ALT≥84 IU/L, total bilirubin≥0.9 mg/dL) for nonresponse were confirmed through multivariate logistic regression analysis. Thus elevated ALT and total bilirubin levels might be useful in predicting nonresponse to IVIG therapy in children with KD.

摘要

目的

据报道,10%至20%的川崎病(KD)患儿对静脉注射免疫球蛋白(IVIG)治疗无反应。在本研究中,我们旨在确定KD患儿治疗失败的有用预测指标。

方法

我们检查了2005年1月至2011年6月期间在庆北国立大学医院和仁济大学釜山白医院诊断为KD的309名儿童。我们回顾性地查阅了他们的病历,并分析了IVIG反应者和无反应者的多个参数。

结果

在这309名儿童中,30名(9.7%)对IVIG无反应。与反应者相比,他们的中性粒细胞比例显著更高,天冬氨酸转氨酶、丙氨酸转氨酶(ALT)、总胆红素和B型利钠肽N端片段水平更高。IVIG无反应者的住院时间显著更长,更频繁地出现冠状动脉病变和无菌性脓尿。在初始治疗时的发热持续时间或临床特征方面未发现差异。

结论

通过多因素逻辑回归分析确定了两个无反应的独立预测指标(ALT≥84 IU/L,总胆红素≥0.9 mg/dL)。因此,ALT和总胆红素水平升高可能有助于预测KD患儿对IVIG治疗的无反应。

相似文献

1
Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease.
Korean J Pediatr. 2013 Feb;56(2):75-9. doi: 10.3345/kjp.2013.56.2.75. Epub 2013 Feb 25.
4
Serum alanine aminotransferase level and intravenous immunoglobulin resistance in patients with kawasaki disease.
Clin Rheumatol. 2022 Oct;41(10):3125-3133. doi: 10.1007/s10067-022-06278-w. Epub 2022 Jul 7.
5
Sterile Pyuria in Kawasaki Disease: A Large Prospective Cohort Study.
Front Cardiovasc Med. 2022 May 11;9:856144. doi: 10.3389/fcvm.2022.856144. eCollection 2022.
8
Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Paediatr Int Child Health. 2018 Aug;38(3):209-212. doi: 10.1080/20469047.2018.1471381. Epub 2018 May 17.

引用本文的文献

1
2
Prevalence of IVIG resistance in Kawasaki disease: a systematic review and meta-analysis.
Front Pediatr. 2025 Jul 4;13:1566590. doi: 10.3389/fped.2025.1566590. eCollection 2025.
5
Clinical features analysis of Kawasaki disease with abdominal symptoms as the first manifestation.
Eur J Pediatr. 2023 Sep;182(9):4049-4057. doi: 10.1007/s00431-023-05086-x. Epub 2023 Jul 3.
7
Serum alanine aminotransferase level and intravenous immunoglobulin resistance in patients with kawasaki disease.
Clin Rheumatol. 2022 Oct;41(10):3125-3133. doi: 10.1007/s10067-022-06278-w. Epub 2022 Jul 7.

本文引用的文献

1
Predicting factors for refractory kawasaki disease.
Korean Circ J. 2010 May;40(5):239-42. doi: 10.4070/kcj.2010.40.5.239. Epub 2010 May 27.
2
Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
Acta Paediatr. 2010 Oct;99(10):1578-83. doi: 10.1111/j.1651-2227.2010.01875.x. Epub 2010 Jun 7.
3
Pathogenesis and management of Kawasaki disease.
Expert Rev Anti Infect Ther. 2010 Feb;8(2):197-203. doi: 10.1586/eri.09.109.
4
The role of b-type natriuretic peptide in heart failure management.
Aust Crit Care. 2009 Aug;22(3):117-23. doi: 10.1016/j.aucc.2009.06.001. Epub 2009 Jul 8.
5
Kawasaki disease.
BMJ. 2009 May 5;338:b1514. doi: 10.1136/bmj.b1514.
6
Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.
Pediatr Cardiol. 2009 Aug;30(6):810-7. doi: 10.1007/s00246-009-9441-2. Epub 2009 Apr 14.
7
NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies.
Pediatr Cardiol. 2009 Jan;30(1):3-8. doi: 10.1007/s00246-008-9258-4. Epub 2008 Jul 4.
8
Resistance to intravenous immunoglobulin in children with Kawasaki disease.
J Pediatr. 2008 Jul;153(1):117-21. doi: 10.1016/j.jpeds.2007.12.021. Epub 2008 Mar 4.
9
Risk factors for nonresponse to therapy in Kawasaki disease.
J Pediatr. 2008 Sep;153(3):365-8. doi: 10.1016/j.jpeds.2008.03.014. Epub 2008 May 16.
10
Sterile pyuria in patients with Kawasaki disease originates from both the urethra and the kidney.
Pediatr Nephrol. 2007 Jul;22(7):987-91. doi: 10.1007/s00467-007-0449-7. Epub 2007 Feb 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验